<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ji C</submitter><funding>NIA NIH HHS</funding><funding>Alzheimer's Association Research Fellowships</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>7954-7970</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11567809</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(11)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>It is unclear how early neuronal deficits occur in tauopathies, if these are associated with changes in neuronal network activity, and if they can be alleviated with therapies.&lt;h4>Methods&lt;/h4>To address this, we performed in vivo two-photon Ca&lt;sup>2+&lt;/sup> imaging in tauopathy mice at 6 versus 12 months, compared to controls, and treated the younger animals with a tau antibody.&lt;h4>Results&lt;/h4>Neuronal function was impaired at 6 months but did not deteriorate further at 12 months, presumably because cortical tau burden was comparable at these ages. At 6 months, neurons were mostly hypoactive, with enhanced neuronal synchrony, and had dysregulated responses to stimulus. Ex vivo, electrophysiology revealed altered synaptic transmission and enhanced excitability of motor c</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy.</pubmed_title><pmcid>PMC11567809</pmcid><funding_grant_id>R01 AG032611</funding_grant_id><funding_grant_id>AARF-22-924783 (Y.J.)</funding_grant_id><funding_grant_id>R01 NS077239</funding_grant_id><funding_grant_id>R21 AG069475</funding_grant_id><funding_grant_id>AARF-22-926735 (C.J.)</funding_grant_id><funding_grant_id>RF1 NS120488</funding_grant_id><funding_grant_id>R01 NS120488</funding_grant_id><funding_grant_id>R01 NS120488 (E.M.S.)</funding_grant_id><funding_grant_id>R21 AG059391</funding_grant_id><funding_grant_id>AARFD-22-926379 (A.M-A)</funding_grant_id><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Ji C</pubmed_authors><pubmed_authors>Eleish M</pubmed_authors><pubmed_authors>Martin-Avila A</pubmed_authors><pubmed_authors>Wu Q</pubmed_authors><pubmed_authors>Tetlow AM</pubmed_authors><pubmed_authors>Song SC</pubmed_authors><pubmed_authors>Sigurdsson EM</pubmed_authors><pubmed_authors>Lin Y</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Gan W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuronal hypofunction and network dysfunction in a mouse model at an early stage of tauopathy.</name><description>&lt;h4>Introduction&lt;/h4>It is unclear how early neuronal deficits occur in tauopathies, if these are associated with changes in neuronal network activity, and if they can be alleviated with therapies.&lt;h4>Methods&lt;/h4>To address this, we performed in vivo two-photon Ca&lt;sup>2+&lt;/sup> imaging in tauopathy mice at 6 versus 12 months, compared to controls, and treated the younger animals with a tau antibody.&lt;h4>Results&lt;/h4>Neuronal function was impaired at 6 months but did not deteriorate further at 12 months, presumably because cortical tau burden was comparable at these ages. At 6 months, neurons were mostly hypoactive, with enhanced neuronal synchrony, and had dysregulated responses to stimulus. Ex vivo, electrophysiology revealed altered synaptic transmission and enhanced excitability of motor c</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-07-16T22:36:40.533Z</modification><creation>2025-04-07T04:31:05.704Z</creation></dates><accession>S-EPMC11567809</accession><cross_references><pubmed>39368113</pubmed><doi>10.1002/alz.14273</doi></cross_references></HashMap>